(Q40177605)

18 September 2017

title

Establishment of an arsenic trioxide-resistant human leukemia cell line that shows multidrug resistance (English)

1 reference

18 September 2017

0 references

multiple drug resistance

1 reference

Tamami Seo

1

1 reference

18 September 2017

Yoshimasa Urasaki

series ordinal

2

1 reference

18 September 2017

Takanori Ueda

series ordinal

3

1 reference

18 September 2017

publication date

1 January 2007

1 reference

International Journal of Hematology

18 September 2017

published in

1 reference

18 September 2017

volume

85

1 reference

18 September 2017

issue

1

1 reference

18 September 2017

page(s)

26-31

1 reference

describes a project that uses

18 September 2017

K562/AS-3

0 references

exact match

https://scigraph.springernature.com/pub.10.1532/ijh97.05142

0 references

cites work

Elevation of glutathione levels and glutathione S-transferase activity in arsenic-resistant Chinese hamster ovary cells

1 reference

12 December 2020

Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies.

1 reference

12 December 2020

Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines

1 reference

12 December 2020

Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.

1 reference

12 December 2020

Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients

1 reference

12 December 2020

Chronic arsenic-exposed human prostate epithelial cells exhibit stable arsenic tolerance: mechanistic implications of altered cellular glutathione and glutathione S-transferase

1 reference

12 December 2020

In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins

1 reference

12 December 2020

Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis

1 reference

12 December 2020

Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines

1 reference

12 December 2020

Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells

1 reference

12 December 2020

Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia.

1 reference

12 December 2020

Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxide.

1 reference

12 December 2020

Reactions of arsenic(III) and arsenic(V) species with glutathione

1 reference

12 December 2020

Long-term follow-up of the clinical efficacy of chemotherapy for acute myeloid leukemia at a single institute

1 reference

12 December 2020

Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry

1 reference

12 December 2020

Inhibition by arsenic trioxide of human hepatoma cell growth

1 reference

12 December 2020

P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) are induced by arsenic trioxide (As(2)O(3)), but are not the main mechanism of As(2)O(3)-resistance in acute promyelocytic leukemia cells

1 reference

12 December 2020

Studies of apoptosis of malignant lymphoma cells induced by arsenic trioxide

1 reference

12 December 2020

Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myeloma

1 reference

12 December 2020

Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro

1 reference

12 December 2020

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

1 reference

12 December 2020

Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.

1 reference

12 December 2020

Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway

1 reference

12 December 2020

Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia

1 reference

12 December 2020

Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide

1 reference

12 December 2020

The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic

1 reference

12 December 2020

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients

1 reference

12 December 2020

The MRP1-mediated effluxes of arsenic and antimony do not require arsenic-glutathione and antimony-glutathione complex formation.

1 reference

12 December 2020

Clinical activity of arsenic trioxide in Burkitt-like lymphoma

1 reference

12 December 2020

Role of the Multidrug Resistance Protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice

1 reference

12 December 2020

Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells

1 reference

12 December 2020

Identifiers

DOI

10.1532/IJH97.05142

1 reference

Dimensions Publication ID

18 September 2017

1052375087

0 references

1 reference